CREDIT AGREEMENTCredit Agreement • November 16th, 2018 • Fortress Biotech, Inc. • Pharmaceutical preparations • Delaware
This CREDIT AGREEMENT, dated as of November 12, 2018 (as may be amended or modified from time to time, this “Agreement”), is entered into by and between AVENUE THERAPEUTICS, INC., a Delaware corporation (the “Borrower”), and INVAGEN PHARMACEUTICALS INC., a New York corporation (the “Lender”).
STOCKHOLDERS AGREEMENTStockholders Agreement • November 16th, 2018 • Fortress Biotech, Inc. • Pharmaceutical preparations • Delaware
THIS STOCKHOLDERS AGREEMENT (as may be amended or modified from time to time, this “Agreement”) is made and entered into as of November 12, 2018, by and among InvaGen Pharmaceuticals Inc., a New York Corporation (“Buyer”), Avenue Therapeutics, Inc., a Delaware corporation (the “Company”), and the stockholders of the Company listed on Schedule A hereto (the “Stockholders” and each individually a “Stockholder”).
GUARANTYFortress Biotech, Inc. • November 16th, 2018 • Pharmaceutical preparations • Delaware
This GUARANTY, dated as of November 12, 2018 (as may be amended or modified from time to time, this “Guaranty”), is made by FORTRESS BIOTECH, INC., a Delaware corporation (“Guarantor”), in favor of INVAGEN PHARMACEUTICALS INC., a New York corporation (the “Lender”).
WAIVER AND TERMINATION AGREEMENTWaiver and Termination Agreement • November 16th, 2018 • Fortress Biotech, Inc. • Pharmaceutical preparations • Delaware
THIS WAIVER AND TERMINATION AGREEMENT (as may be amended or modified from time to time, this “Agreement”) is entered into on November 12, 2018, by and among Fortress Biotech, Inc., a Delaware corporation (“Fortress”), Avenue Therapeutics, Inc., a Delaware corporation (the “Company”), and InvaGen Pharmaceuticals Inc., a New York corporation (“Buyer”).
